Blog

Slide image for Polsinelli Shughart WGN Toy Drive

Polsinelli Shughart Joins WGN Toy Drive To Give Back This Holiday Season 2

By Techli 17 diciembre, 2012

This year the law offices of Polsinelli Shughart have joined forces with Presence Healthcare to participate in WGN’s annual holiday toy drive. For the past decade, WGN has been working with Chicago businesses to bring toys to the city’s children in need during the holiday season. In its first...

SLU Researchers Land $1.8 Million For Lupus Research 3

By Techli 17 diciembre, 2012

Lupus is a mysterious chronic inflammatory disease that has no cure. Now, researchers in Saint...

Cheers To The Chicago Startup Scene With Hireology At Entrepreneur’s Eve 4

By Techli 17 diciembre, 2012

Toast the Chicago startup scene together with over 100 entrepreneurs and small businesses including...

1.3 Million Android Devices Activated Daily; Beats iOS Marketshare 5

By Techli 16 diciembre, 2012

It's official- the Android OS is now bigger than Apple's iOS and the gap is only going to get...

CEO Sundays: Ken Oboh on The Importance of Passion 6

By Techli 16 diciembre, 2012

  The world of business is often thought of as cold and heartless. Tall skyscrapers employing...

Slide image for StyleSeek Ugly Sweater holidays

StyleSeek Decks The Halls With Ugly Sweaters 7

By Techli 15 diciembre, 2012

Having trouble finding the ugliest holiday sweater for your ugly holiday sweater party? Chicago’s...

Slide for Voicle's CliQs

CliQs Makes Friends From Facebook Acquaintances 8

By Techli 15 diciembre, 2012

This week Champaign-based startup Voicle released a new hybrid social/gaming app for iOS called...

Flash Is Not Dead (Yet) And Other Lessons From Adobe’s Create The Web Tour 9

By Techli 14 diciembre, 2012

As the final leg of Adobe's Create The Web Tour draws near, one question remains in the front of...

vaccine

St. Louis Arch Angels-Backed Sequoia Sciences To Start Vaccine Clinical Trials 10

By Techli 14 diciembre, 2012

St. Louis-based Sequoia Sciences is preparing to start phase 1 of clinical trials for a vaccine...